[1] NICOLLE C, MANCEAUX L. Sur une infection a corps de Leishman (ou organismes voisons) du gondi[J]. Compt Rend Acad D Sci, 1908, 147:736-766.
[2] ZHAO G W, WANG S, WANG W, et al. Type I strain of Toxoplasma gondii from chicken induced different immune responses with that from human,cat and swine in chicken[J]. J Integr Agr, 2015, 14(5):956-965.
[3] 曾艳波, 朱顺海, 韩红玉, 等. 抗急性弓形虫病药物疗效的研究[J]. 中国人兽共患病学报, 2011, 27(4):316-319, 324.
ZENG Y B, ZHU S H, HAN H Y, et al. Efficacy on different kinds of drugs against acute murine toxoplasmosis[J]. Chinese Journal of Zoonoses, 2011, 27(4):316-319, 324. (in Chinese)
[4] BUXTON D. Toxoplasmosis:the first commercial vaccine[J]. Parasitol Today, 1993, 9(9):335-337.
[5] HASSAN I A, WANG S, XU L X, et al. Immunoglobulin and cytokine changes induced following immunization with a DNA vaccine encoding Toxoplasma gondii selenium-dependent glutathione reductase protein[J]. Exp Parasitol, 2014, 146:1-10.
[6] KUR J, HOLEC-G?SIOR L, HISZCZY ? SKA-SAWICKA E. Current status of toxoplasmosis vaccine development[J]. Expert Rev Vaccines, 2009, 8(6):791-808.
[7] LIM S S Y, OTHMAN R Y. Recent advances in Toxoplasma gondii immunotherapeutics[J]. Korean J Parasitol, 2014, 52(6):581-593.
[8] NAGAMUNE K, MORENO S N, CHINI E N, et al. Calcium regulation and signaling in apicomplexan parasites[M]. BURLEIGH B A, SOLDATI-FAVRE D. Molecular mechanisms of parasite invasion. New York:Springer, 2008.
[9] STEWART R J, WHITEHEAD L, NIJAGAL B, et al. Analysis of Ca2+ mediated signaling regulating Toxoplasma infectivity reveals complex relationships between key molecules[J]. Cell Microbiol, 2016, doi:10.1111/cmi.12685.
[10] WANG J L, ZHANG N Z, HUANG S Y, et al. Low-level sequence variation in Toxoplasma gondii calcium-dependent protein kinases among different genotypes[J]. Genet Mol Res, 2015, 14(2):4949-4956.
[11] ZHANG Z C, HUANG J W, LI M H, et al. Identification and molecular characterization of microneme 5 of Eimeria acervulina[J]. PLoS One, 2014, 9(12):e115411.
[12] DUNAY I R, DAMATTA R A, FUX B, et al. Gr1+ inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii[J]. Immunity, 2008, 29(2):306-317.
[13] DUNAY I R, FUCHS A, SIBLEY L D. Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice[J]. Infect Immun, 2010, 78(4):1564-1570.
[14] MOSSER D M, EDWARDS J P. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008, 8(12):958-969.
[15] 赵中兴, 傅小平, 沈永林. 一氧化氮抗寄生虫感染的研究进展[J]. 动物医学进展, 2004, 25(1):49-52.
ZHAO Z X, FU X P, SHEN Y L. Research advances of nitric oxide against parasitic infection[J]. Progress in Veterinary Medicine, 2004, 25(1):49-52. (in Chinese)
[16] 黄开顺, 黄天利, 葛璞, 等. 刚地弓形虫培养上清对人肝癌细胞HepG2增殖及凋亡的作用[J]. 激光杂志, 2013, 34(1):98-99,101.
HUANG K S, HUANG T L, GE P, et al. Effects of culture supernatant of toxoplasma gondii on proliferation and apoptosis of hepatoma cell Line HepG2[J]. Laser Journal, 2013, 34(1):98-99,101. (in Chinese)
[17] FLORIO T, THELLUNG S, ARENA S, et al. Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro[J]. Eur J Endocrinol, 1999, 141(4):396-408.
[18] ZHANG T C, CAO E H, LI J F, et al. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide[J]. Eur J Cancer, 1999, 35(8):1258-1263.
[19] 王力俭, 田可川, 吴伟伟, 等. 细胞凋亡信号传导通路的研究进展[J]. 中国畜牧兽医, 2011, 38(10):132-135.
WANG L J, TIAN K C, WU W W, et al. Recent advances on the signal transduction pathways of apoptosis[J]. China Animal Husbandry & Veterinary Medicine, 2011, 38(10):132-135. (in Chinese)
[20] DINCEL G C, ATMACA H T. Nitric oxide production increases during Toxoplasma gondii encephalitis in mice[J]. Exp Parasitol, 2015, 156:104-112.
[21] HUNTER C A, CHIZZONITE R, REMINGTON J S. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. A role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens[J]. J Immunol, 1995, 155(9):4347-4354.
[22] DUPONT C D, CHRISTIAN D A, HUNTER C A. Immune response and immunopathology during toxoplasmosis[J]. Semin Immunopathol, 2012, 34(6):793-813.
[23] 缪明远, 牛轶雯, 陆树良. 巨噬细胞活化与创面愈合[J]. 上海交通大学学报:医学版, 2011, 31(8):1189-1193.
MIAO M Y, NIU Y W, LU S L. Macrophage activation and wound healing[J]. Journal of Shanghai Jiaotong University:Medical Science, 2011, 31(8):1189-1193. (in Chinese)
[24] ZARE-BIDAKI M, ASSAR S, HAKIMI H, et al. TGF-β in Toxoplasmosis:Friend or foe?[J]. Cytokine, 2016, 86:29-35.
[25] NASEF A, CHAPEL A, MAZURIER C, et al. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells[J]. Gene Expr, 2007, 13(4-5):217-226.
[26] GAZZINELLI R T, WYSOCKA M, HIENY S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α[J]. J Immunol, 1996, 157(2):798-805. |